High Mobility Group Box 1 Gene Polymorphism and Serum High Mobility Group Box 1, Interleukin 1 Beta, and Alpha-Klotho Crosstalk in Severe COVID-19 Patients

References

• Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., Li, W. W., Li, V. W., Mentzer, S. J., & Jonigk, D. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. The New England Journal of Medicine, 383(2), 120–128. https://doi.org/10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Andersson, U., Ottestad, W., & Tracey, K. J. (2020). Extracellular HMGB1: A therapeutic target in severe pulmonary inflammation including COVID-19? Molecular Medicine, 26(1), 1–13. https://doi.org/10.1186/s10020-020-00172-4
   Web of Science ®Google Scholar
• Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., Tracey, K. J. (2000). High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine, 192(4), 565–570. https://doi.org/10.1084/jem.192.4.565
   PubMed Web of Science ®Google Scholar
• Bao, G., Qu, F., He, L., Zhao, H., Wang, N., Ji, G., & He, X. (2016). Prognostic significance of tag SNP rs1045411 in HMGB1 of the aggressive gastric cancer in a Chinese population. PLoS One, 11(4), e0154378. https://doi.org/10.1371/journal.pone.0154378
   PubMed Web of Science ®Google Scholar
• Bester, J., & Pretorius, E. (2016). Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Scientific Reports, 6(1), 32188. https://doi.org/10.1038/srep32188
   PubMedGoogle Scholar
• Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, Cotran, R. S., & Gimbrone, M. A. (1984). Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. Journal of Experimental Medicine, 160(2), 618–623. https://doi.org/10.1084/jem.160.2.618
   PubMed Web of Science ®Google Scholar
• Chen, R., Huang, Y., Quan, J., Liu, J., Wang, H., Billiar, T. R., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2020). HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon, 6(12), e05672. https://doi.org/10.1016/j.heliyon.2020.e05672
   PubMed Web of Science ®Google Scholar
• Connors, J. M., & Levy, J. H. (2020). COVID-19 and its implications for thrombosis and anticoagulation. Blood, the Journal of the American Society of Hematology, 135(23), 2033–2040. https://doi.org/10.1182/blood.2020006000
   Google Scholar
• Dinarello, C. A., Simon, A., & Van Der Meer, J. W. (2012). Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nature Reviews Drug Discovery, 11(8), 633–652. https://doi.org/10.1038/nrd3800
   PubMed Web of Science ®Google Scholar
• Feng, Z., Diao, B., Wang, R., Wang, G., Wang, C., Tan, Y., Liu, L., Wang, C., Liu, Y., Liu, Y., & Yuan, Z. (2020). The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. MedRxiv, 2020–2023. https://doi.org/10.1101/2020.03.27.20045427
   Google Scholar
• Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., Du, B., Li, L.-J., Zeng, G., Yuen, K.-Y., Chen, R.-C., Tang, C.-L., Wang, T., Chen, P.-Y., Xiang, J., … Zhu, S.-Y. (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Gupta, P., Ghosh, S., Nagarajan, A., Mehta, V. S., & Sen, E. (2013). β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells. Cellular Signalling, 25(3), 682–689. https://doi.org/10.1016/j.cellsig.2012.12.001
   PubMed Web of Science ®Google Scholar
• Hu, W., Liu, P. Y., Yang, Y. C., Chen, P.-C., Su, C.-M., Chao, C.-C., & Tang, C.-H. (2017). Association of HMGB1 gene polymorphisms with lung cancer susceptibility and clinical aspects. International Journal of Medical Sciences, 14(12), 1197–1202. https://doi.org/10.7150/ijms.20933
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Wang, J. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Li, W., Li, J., Sama, A. E., & Wang, H. (2013). Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release. Molecular Medicine, 19(1), 203–211. https://doi.org/10.2119/molmed.2013.00064
   PubMedGoogle Scholar
• Lin, C. W., Chou, Y. E., Yeh, C. M., Yang, S.-F., Chuang, C.-Y., & Liu, Y.-F. (2017). A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma. Oncotarget, 8(21), 34630–34642. https://doi.org/10.18632/oncotarget.16120
   PubMedGoogle Scholar
• Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet, 395(10229), 1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Nakanishi, K., Nishida, M., Taneike, M., Yamamoto, R., Moriyama, T., & Yamauchi-Takihara, K. (2021). Serum klotho levels contribute to the prevention of disease progression. International Journal of General Medicine, 14, 229–236. https://doi.org/10.2147/IJGM.S291437
   PubMed Web of Science ®Google Scholar
• Nawroth, P. P., Handley, D. A., Esmon, C. T., & Stern, D. M. (1986). Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proceedings of the National Academy of Sciences, 83(10), 3460–3464. https://doi.org/10.1073/pnas.83.10.3460
   PubMed Web of Science ®Google Scholar
• Olajide, O. A., Iwuanyanwu, V. U., Lepiarz-Raba, I., & Al-Hindawi, A. A. (2021). Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone. Inflammation, 44(5), 1865–1877. https://doi.org/10.1007/s10753-021-01464-5
   PubMed Web of Science ®Google Scholar
• Rodrigues, T. S., de Sá, K. S., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., Veras, F. P., Toller-Kawahisa, J. E., Nascimento, D. C., de Lima, M. H. F., Silva, C. M. S., Caetite, D. B., Martins, R. B., Castro, I. A., Pontelli, M. C., … Louzada-Junior, P. (2021). Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. Journal of Experimental Medicine, 218(3), e20201707. https://doi.org/10.1084/jem.20201707
   PubMed Web of Science ®Google Scholar
• Rotondi, S., Pasquali, M., Tartaglione, L., Muci, M. L., Mandanici, G., Leonangeli, C., Sales, S., Farcomeni, A., & Mazzaferro, S. (2015). Soluble α-klotho serum levels in chronic kidney disease. International Journal of Endocrinology, 2015, 1–8. https://doi.org/10.1155/2015/872193
   Web of Science ®Google Scholar
• Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418(6894), 191–195. https://doi.org/10.1038/nature00858
   PubMed Web of Science ®Google Scholar
• Sha, Y., Zmijewski, J., Xu, Z., & Abraham, E. (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. Journal of Immunology, 180(4), 2531–2537. https://doi.org/10.4049/jimmunol.180.4.2531
   PubMed Web of Science ®Google Scholar
• Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020). The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 363–374. https://doi.org/10.1038/s41577-020-0311-8
   PubMed Web of Science ®Google Scholar
• Typiak, M., & Piwkowska, A. (2021). Antiinflammatory actions of klotho: Implications for therapy of diabetic nephropathy. International Journal of Molecular Sciences, 22(2), 956. https://doi.org/10.3390/ijms22020956
   PubMed Web of Science ®Google Scholar
• Unemura, K., Kume, T., Kondo, M., Maeda, Y., Izumi, Y., & Akaike, A. (2012). Glucocorticoids decrease astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo. Journal of Pharmacological Sciences, 119(1), 30–39. https://doi.org/10.1254/jphs.12047FP
   PubMed Web of Science ®Google Scholar
• Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet, 395(10234), 1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5
   PubMed Web of Science ®Google Scholar
• Vogel, S., Bodenstein, R., Chen, Q., Feil, S., Feil, R., Rheinlaender, J., Schäffer, T. E., Bohn, E., Frick, J.-S., Borst, O., Münzer, P., Walker, B., Markel, J., Csanyi, G., Pagano, P. J., Loughran, P., Jessup, M. E., Watkins, S. C., Bullock, G. C., … Gawaz, M. (2015). Platelet-derived HMGB1 is a critical mediator of thrombosis. Journal of Clinical Investigation, 125(12), 4638–4654. https://doi.org/10.1172/JCI81660
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-2019) situation reports. Retrieved December 12, 2022, from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
   Google Scholar
• World Health Organization. (2022). Living guidance for clinical management of COVID-19: Living guidance. Retrieved December 20, 2022, from https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2
   Google Scholar
• Wu, S. E., & Chen, W. L. (2022). Soluble klotho as an effective biomarker to characterize inflammatory states. Annals of Medicine, 54(1), 1520–1529. https://doi.org/10.1080/07853890.2022.2077428
   PubMed Web of Science ®Google Scholar
• Wyganowska-Swiatkowska, M., Nohawica, M., Grocholewicz, K., & Nowak, G. (2020). Influence of herbal medicines on HMGB1 release, SARS-CoV-2 viral attachment, acute respiratory failure, and sepsis. A literature review. International Journal of Molecular Sciences, 21(13), 4639. https://doi.org/10.3390/ijms21134639
   PubMed Web of Science ®Google Scholar
• Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020). High expression of ACE2 receptor of 2019-nCov on the epithelial cells of oral mucosa. International Journal of Oral Science, 12(1), 1–5. https://doi.org/10.1038/s41368-020-0074-x
   PubMed Web of Science ®Google Scholar